(Q46568714)

23 December 2017

title

Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma (English)

1 reference

23 December 2017

author name string

Rehan Khan

1

1 reference

23 December 2017

Manoj Sharma

2

1 reference

23 December 2017

Lalit Kumar

3

1 reference

23 December 2017

Syed Akhtar Husain

4

1 reference

23 December 2017

Alpana Sharma

5

1 reference

23 December 2017

publication date

13 September 2012

1 reference

23 December 2017

published in

Annals of Hematology

1 reference

23 December 2017

volume

92

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

101-109

1 reference

23 December 2017

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

1 reference

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Bone marrow angiogenesis in patients with active multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Cyclooxygenases in cancer: progress and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

COX-2 inhibitors. A new class of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

How to make tubes: signaling by the Met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiopoietins in tumours: the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Exploring the genomes of cancer cells: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Thiothalidomides: Novel Isosteric Analogues of Thalidomide with Enhanced TNF-α Inhibitory Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Not just angiogenesis--wider roles for the angiopoietins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1572-5

10.1007/S00277-012-1572-5

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

22971811

1 reference

23 December 2017